[Among patients with mild ischemic stroke or high-risk TIA, does combined clopidogrel-aspirin therapy initiated within 72hours after stroke onset and given for 21 days reduce the recurrence of stroke at 90 days compared to aspirin alone, and is it safe?]

Rev Med Interne. 2024 Apr;45(4):251-252. doi: 10.1016/j.revmed.2024.02.002. Epub 2024 Feb 22.
[Article in French]
No abstract available

Keywords: Accident vasculaire cérébral; Antiplatelet therapy; Aspirin; Aspirine; Clopidogrel; Stroke; Thérapie antiplaquettaire.

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aspirin* / administration & dosage
  • Aspirin* / adverse effects
  • Aspirin* / therapeutic use
  • Clopidogrel* / administration & dosage
  • Clopidogrel* / adverse effects
  • Clopidogrel* / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Ischemic Attack, Transient* / drug therapy
  • Ischemic Attack, Transient* / prevention & control
  • Ischemic Stroke* / drug therapy
  • Ischemic Stroke* / prevention & control
  • Platelet Aggregation Inhibitors* / administration & dosage
  • Platelet Aggregation Inhibitors* / adverse effects
  • Platelet Aggregation Inhibitors* / therapeutic use
  • Recurrence*
  • Risk Factors
  • Secondary Prevention* / methods
  • Secondary Prevention* / standards
  • Stroke / etiology
  • Stroke / prevention & control
  • Time Factors
  • Treatment Outcome

Substances

  • Clopidogrel
  • Aspirin
  • Platelet Aggregation Inhibitors